Trilantic Europe and Alto Partners will merge their portfolio companies Doppel Farmaceutici and Mipharm, respectively, to form Domixtar Pharmaceuticals (DMX Pharma), whose shares will be held 50/50 by the two funds.
Our firm advised Alto Partners and Mipharm with a multidisciplinary team composed of partner Ciro Di Palma, associates Michela Maresca, Gianluca Diena and Beatrice Mattioni, and trainee Filippo Ghanaymi for corporate aspects, of partner Andrea Taurozzi and associate Edoardo Testagrossa for finance aspects, as well as of partner Lorenzo Caruccio and associate Davide D'Occhio for public law related matters.